FDA NDC Directory · JSON-LD · Markdown

LANTIDRA

NDC 73539-001 · CELLULAR THERAPY · SOLUTION

Generic nameDONISLECEL
Labeler / ManufacturerCellTrans Inc.
Marketing categoryBiologic License Application · App BLA125734
Dosage form / routeSOLUTION · INTRAVASCULAR
Active ingredientsDONISLECEL (5000 [arb'U]/400mL)
Marketing started20230628
Package count1

External sources

Source: openFDA. Public-domain (CC0).